Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

Microtubule Associated Proteins (MAPs)

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Destabilization of Microtubules

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...

Microtubule Instability

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Parkin absence accelerates microtubule aging in dopaminergic neurons.

Neurobiology of aging·2017

Same author

A novel immunotoxin reveals a new role for CD321 in endothelial cells.

PloS one·2017

Same author

Deep cerebral venous thrombosis mimicking influenza-associated acute necrotizing encephalopathy: a case report.

Journal of medical case reports·2017

Same author

Chronic subdural haematoma presenting as freezing of gait.

BMJ case reports·2017

Same author

Subthalamic nucleus and globus pallidus interna influence firing of tonically active neurons in the primate striatum through different mechanisms.

The European journal of neuroscience·2017

Same author

Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2017

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Parkin stabilizes PINK1 through direct interaction.

Kahori Shiba¹, Takeo Arai, Shigeto Sato

¹Research Institute for Diseases of Old Age, Juntendo University School of Medicine, Hongo, Bunkyo, Tokyo, Japan.

Biochemical and Biophysical Research Communications

|April 11, 2009

Summary

Parkin directly interacts with PINK1, stabilizing it and preventing degradation. This interaction is crucial for understanding the common pathway in early-onset Parkinson disease pathogenesis.

More Related Videos

Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Jun 24, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Published on: May 12, 2023

Area of Science:

Neuroscience
Molecular Biology
Genetics

Background:

Parkinson disease (PD) is a common movement disorder caused by dopaminergic dysfunction.
Familial PD genetics, including PARK2 (parkin) and PINK1 (PARK6), offers insights into disease mechanisms.

Purpose of the Study:

To investigate the interaction between Parkin and PINK1 in Parkinson disease pathogenesis.
To elucidate the role of Parkin in regulating PINK1 stability and function.

Main Methods:

Investigated direct protein-protein interactions between Parkin and PINK1.
Assessed the effect of Parkin on PINK1 degradation via the ubiquitin-proteasomal pathway.
Analyzed changes in protein solubility upon Parkin-PINK1 interaction.

Main Results:

Parkin directly interacts with wild-type PINK1 but not pathogenic PINK1 mutants.
Parkin binding stabilizes PINK1 by inhibiting its proteasomal degradation.
The Parkin-PINK1 interaction leads to reduced solubility of both proteins.

Conclusions:

Parkin regulates PINK1 stabilization through direct interaction.
Parkin and PINK1 function in a common pathway implicated in early-onset Parkinson disease.